These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 38067477)
1. Computational Modeling Study of the Binding of Aging and Non-Aging Inhibitors with Neuropathy Target Esterase. Wu W; Wang P Molecules; 2023 Nov; 28(23):. PubMed ID: 38067477 [TBL] [Abstract][Full Text] [Related]
2. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998 [TBL] [Abstract][Full Text] [Related]
3. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds. Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094 [TBL] [Abstract][Full Text] [Related]
4. Interactions in vitro of some organophosphoramidates with neuropathy target esterase and acetylcholinesterase of hen brain. Jokanovic M; Johnson MK J Biochem Toxicol; 1993 Mar; 8(1):19-31. PubMed ID: 8492300 [TBL] [Abstract][Full Text] [Related]
5. Discrimination of carboxylesterases of chicken neural tissue by inhibition with a neuropathic, non-neuropathic organophosphorus compounds and neuropathy promoter. Céspedes MV; Escudero MA; Barril J; Sogorb MA; Vicedo JL; Vilanova E Chem Biol Interact; 1997 Oct; 106(3):191-200. PubMed ID: 9413546 [TBL] [Abstract][Full Text] [Related]
7. The role of neurotoxic esterase (NTE) in the prevention and potentiation of organophosphorus-induced delayed neurotoxicity (OPIDN). Pope CN; Tanaka D; Padilla S Chem Biol Interact; 1993 Jun; 87(1-3):395-406. PubMed ID: 8343996 [TBL] [Abstract][Full Text] [Related]
8. Neuropathy target esterase (NTE) and organophosphorus-induced delayed polyneuropathy (OPIDP): recent advances. Johnson MK; Glynn P Toxicol Lett; 1995 Dec; 82-83():459-63. PubMed ID: 8597094 [TBL] [Abstract][Full Text] [Related]
9. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds. Makhaeva GF; Sigolaeva LV; Zhuravleva LV; Eremenko AV; Kurochkin IN; Malygin VV; Richardson RJ J Toxicol Environ Health A; 2003 Apr; 66(7):599-610. PubMed ID: 12746135 [TBL] [Abstract][Full Text] [Related]
11. High doses of soman protect against organophosphorus-induced delayed polyneuropathy but tabun does not. Johnson MK; Willems JL; De Bisschop HC; Read DJ; Benschop HP Toxicol Appl Pharmacol; 1988 Jan; 92(1):34-41. PubMed ID: 3341026 [TBL] [Abstract][Full Text] [Related]
12. Inhibition and aging of neuropathy target esterase by the stereoisomers of a phosphoramidate related to methamidophos. Sogorb MA; Díaz-Alejo N; Pellín MC; Vilanova E Toxicol Lett; 1997 Dec; 93(2-3):95-102. PubMed ID: 9486944 [TBL] [Abstract][Full Text] [Related]
13. QSAR for the organophosphate-induced inhibition and 'aging' of the enzyme neuropathy target esterase (NTE). Singh AK SAR QSAR Environ Res; 2001; 12(3):275-95. PubMed ID: 11696925 [TBL] [Abstract][Full Text] [Related]
14. Reversible inhibition can profoundly mislead studies on progressive inhibition of enzymes: the interaction of paraoxon with soluble neuropathy target esterase. Barril J; Vilanova E Chem Biol Interact; 1997 Dec; 108(1-2):19-25. PubMed ID: 9463518 [TBL] [Abstract][Full Text] [Related]
15. Actions of two highly potent organophosphorus neuropathy target esterase inhibitors in mammalian cell lines. Li W; Casida JE Toxicol Lett; 1997 Jul; 92(2):123-30. PubMed ID: 9295235 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of organophosphorus-induced delayed neurotoxicity following phenyl saligenin phosphate exposures in 2-, 5-, and 8-week-old chickens. Harp P; Tanaka D; Pope CN Fundam Appl Toxicol; 1997 May; 37(1):64-70. PubMed ID: 9193923 [TBL] [Abstract][Full Text] [Related]
17. Neuropathy target esterase of hen brain: active site reactions with 2-[octyl-3H]octyl-4H-1,3,2-benzodioxaphosphorin 2-oxide and 2-octyl-4H-1,3,2-[aryl-3H]benzodioxaphosphorin 2-oxide. Yoshida M; Tomizawa M; Wu SY; Quistad GB; Casida JE J Neurochem; 1995 Apr; 64(4):1680-7. PubMed ID: 7891095 [TBL] [Abstract][Full Text] [Related]
18. The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss. Kropp TJ; Glynn P; Richardson RJ Biochemistry; 2004 Mar; 43(12):3716-22. PubMed ID: 15035642 [TBL] [Abstract][Full Text] [Related]
19. A comparative study of inhibition of acetylcholinesterase, trypsin, neuropathy target esterase, and spleen cell activation by structurally related organophosphorus compounds. Pruett SB; Chambers HW; Chambers JE J Biochem Toxicol; 1994 Dec; 9(6):319-27. PubMed ID: 7891368 [TBL] [Abstract][Full Text] [Related]
20. Symposium introduction: retrospect and prospects for neuropathy target esterase (NTE) and the delayed polyneuropathy (OPIDP) induced by some organophosphorus esters. Johnson MK Chem Biol Interact; 1993 Jun; 87(1-3):339-46. PubMed ID: 8343991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]